Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 2—February 2009
Dispatch

European Bat Lyssavirus Transmission among Cats, Europe

Laurent DacheuxComments to Author , Florence Larrous, Alexandra Mailles, Didier Boisseleau, Olivier Delmas, Charlotte Biron, Christiane Bouchier, Isabelle Capek, Michel Muller, Frédéric Ilari, Tanguy Lefranc, François Raffi, Maryvonne Goudal, and Hervé Bourhy
Author affiliations: Institut Pasteur, Paris, France (L. Dacheux, F. Larrous, O. Delmas, C. Bouchier, M. Goudal, H. Bourhy); Institut de Veille Sanitaire, Saint-Maurice, France (A. Mailles, I. Capek); Direction Départementale des Services Vétérinaires de la Vendée, La Roche-sur-Yon, France (D. Boisseleau); Centre Hospitalier Universitaire de Nantes, Nantes, France (C. Biron, F. Raffi); Clinique Vétérinaire du Bas-Poitou, Fontenay-le-Comte, France (M. Muller); Clinique Vétérinaire Roosevelt, Vannes, France (F. Ilari, T. Lefranc)

Main Article

Figure 1

Phylogenetic tree comparing nucleotide sequences of A) nucleoprotein (372 nt, position 63 from the translation initiation site) and B) glycoprotein (547 nt, position 640 from the translation initiation site) genes of spillover transmission of European bat lyssavirus-1 (EBLV-1) in terrestrial mammals and human with representative isolates of the diversity of EBLV-1 in Europe. Cases described in this report are indicated by the arrows. For each dataset, we inferred a maximum clade credibility phyl

Figure 1. Phylogenetic tree comparing nucleotide sequences of A) nucleoprotein (372 nt, position 63 from the translation initiation site) and B) glycoprotein (547 nt, position 640 from the translation initiation site) genes of spillover transmission of European bat lyssavirus-1 (EBLV-1) in terrestrial mammals and human with representative isolates of the diversity of EBLV-1 in Europe. Cases described in this report are indicated by the arrows. For each dataset, we inferred a maximum clade credibility phylogenetic tree by using the Bayesian Markov Chain Monte Carlo method available in the Bayesian Evolutionary Analysis Sampling Trees software (http://beast.bio.ed.ac.uk). This analysis used a relaxed (uncorrelated lognormal) molecular clock and the HKY85 + Γ4 model of nucleotide substitution. All horizontal branches are scaled according to the number of substitutions per site. Bootstrap values are indicated at the nodes. All GenBank accession numbers corresponding to full-length or partial nucleoprotein and glycoprotein nucleotide sequences were previously described (2,10) except for nucleoprotein nucleotide sequences of isolates 03011FRA (EU636795), 04032FRA (EU636794), 05001FRA (EU636790), 05002FRA (EU636789), 06001FRA (EU636791), 06002FRA (EU636792), and 070057FRA (EU636793) and glycoprotein nucleotide sequences of isolates 03011FRA (EU636787) and 04032FRA (EU636788).

Main Article

References
  1. Bourhy  H, Dacheux  L, Strady  C, Mailles  A. Rabies in Europe in 2005. Euro Surveill. 2005;10:213–6.PubMedGoogle Scholar
  2. Davis  PL, Holmes  EC, Larrous  F, Van der Poel  WH, Tjørnehøj  K, Alonso  WJ, Phylogeography, population dynamics, and molecular evolution of European bat lyssaviruses. J Virol. 2005;79:10487–97. DOIPubMedGoogle Scholar
  3. Harris  SL, Brookes  SM, Jones  G, Hutson  AM, Racey  PA, Aegerter  J, European bat lyssaviruses: distribution, prevalence and implications for conservation. Biol Conserv. 2006;131:193–210. DOIGoogle Scholar
  4. Vos  A, Kaipf  I, Denzinger  A, Fooks  AR, Johnson  N, Müller  T. European bat lyssaviruses: an ecological enigma. Acta Chiropt. 2007;9:283–96. DOIGoogle Scholar
  5. Amengual  B, Bourhy  H, López-Roig  M, Serra-Cobo  J. Temporal dynamics of European bat lyssavirus type 1 and survival of Myotis myotis bats in natural colonies. PLoS One. 2007;2:e566. DOIPubMedGoogle Scholar
  6. Tjørnehøj  K, Fooks  AR, Agerholm  JS, Rønsholt  L. Natural and experimental infection of sheep with European bat lyssavirus type-1 of Danish bat origin. J Comp Pathol. 2006;134:190–201. DOIPubMedGoogle Scholar
  7. Müller  T, Cox  J, Peter  W, Schäfer  R, Johnson  N, McElhinney  LM, Spill-over of European bat lyssavirus type 1 into a stone marten (Martes foina) in Germany. J Vet Med B Infect Dis Vet Public Health. 2004;51:49–54. DOIPubMedGoogle Scholar
  8. World Health Organization. WHO expert consultation on rabies. World Health Organ Tech Rep Ser. 2005;931:1–88.PubMedGoogle Scholar
  9. Xu  G, Weber  P, Hu  Q, Xue  H, Audry  L, Li  C, A simple sandwich ELISA (WELYSSA) for the detection of lyssavirus nucleocapsid in rabies suspected specimens using mouse monoclonal antibodies. Biologicals. 2007;35:297–302. DOIPubMedGoogle Scholar
  10. Delmas  O, Holmes  EC, Talbi  C, Larrous  F, Dacheux  L, Bouchier  C, Genomic diversity and evolution of the lyssaviruses. PLoS One. 2008;3:e2057. DOIPubMedGoogle Scholar
  11. Conseil Supérieur d’Hygiène Publique de France (CSHPF). Recommandations pour limiter l’exposition du public aux virus de la rage des chauves-souris. Bulletin Epidémiologique Hebdomadaire. 2001;39:193.
  12. Takumi  K, Lina  PH, van der Poel  WH, Kramps  JA, van der Giessen  JW. Public health risk analysis of European bat lyssavirus infection in The Netherlands. Epidemiol Infect. 2008;21:1–7. DOIGoogle Scholar
  13. Tjørnehøj  K, Rønsholt  L, Fooks  AR. Antibodies to EBLV-1 in a domestic cat in Denmark. Vet Rec. 2004;155:571–2.PubMedGoogle Scholar
  14. Brookes  SM, Klopfleisch  R, Müller  T, Healy  DM, Teifke  JP, Lange  E, Susceptibility of sheep to European bat lyssavirus type-1 and -2 infection: a clinical pathogenesis study. Vet Microbiol. 2007;125:210–23. DOIPubMedGoogle Scholar
  15. Marston  DA, McElhinney  LM, Johnson  N, Müller  T, Conzelmann  KK, Tordo  N, Comparative analysis of the full genome sequence of European bat lyssavirus type 1 and type 2 with other lyssaviruses and evidence for a conserved transcription termination and polyadenylation motif in the G-L 3′ non-translated region. J Gen Virol. 2007;88:1302–14. DOIPubMedGoogle Scholar

Main Article

Page created: December 08, 2010
Page updated: December 08, 2010
Page reviewed: December 08, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external